Huntington National Bank Northwest Biotherapeutics Inc Transaction History

Huntington National Bank

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 10, 2022	SELL	$0.7 - $0.98 $875 - $1,225	-1,250 Closed	0 $0
Q4 2021 Jan 21, 2022	BUY	$0.6 - $1.26 $750 - $1,575	1,250 New	1,250 $0
Q1 2019 Apr 09, 2019	SELL	$0.21 - $0.34 $5,250 - $8,500	-25,000 Closed	0 $0
Q4 2018 Jan 28, 2019	BUY	$0.19 - $0.3 $4,750 - $7,500	25,000 New	25,000 $5,000

688K

Ticker NWBO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,037,230,016
Market Cap $332M
Description
Northwest Biotherapeutics, Inc., a biotechnology company, develops personalized immune therapies for cancer in the United States and internationally. The company develops its products based on DCVax, a platform technology that uses activated dendritic cells to mobilize a patient's own immune system to attack cancer. Its lead product, DCVax-L, wh...

Get notified when there are updates to the investment portfolio of Huntington National Bank, based on Form 13F filings with the SEC.

Stay updated on Huntington National Bank with notifications on news.